Abstract
There is no medical cure for obesity and, despite the numerous dietary treatments, the natural course of the disease is characterized by an ongoing, sometimes unstoppable, weight gain. There are now one billion overweight or obese persons worldwide, but only some of these patients express the desire or are able to undergo a surgical operation.
In this context, the intragastric balloon can play a very clear role in interrupting the ongoing weight gain and in achieving positive control or resolution or improving of the relevant comorbidities.
The balloon system is indicated for temporary use associated with a specific diet treatment in patients with a history of obesity, after numerous failures of the dietary treatment only.
This chapter explores the history of intragastric balloons, their differences as well as the indications, technical notes and complications of the intragastric balloon treatment, with particular attention to the state-of-the-art of long-term results.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ogunnaike BO, Jones SB, Jones DB, et al. Anesthetic considerations for bariatric surgery. Anesth Analg. 2002;95:1793–805.
Pasulka PS, Bistrian BR, Benotti PN, et al. The risks of surgery in obese patients. Ann Intern Med. 1986;104:540–6.
Lindor KD, Hughes Jr RW, Ilstrup DM, et al. Intragastric balloons in comparison with standard therapy for obesity — a randomized, double-blind trial. Mayo Clin Proc. 1987;62(11):992–6.
Lecumberri E, Krekshi W, Matía P, et al. Effectiveness and safety of air-filled balloon Heliosphere BAG® in 82 consecutive obese patients. Obes Surg. 2011;21(10):1508–12.
Gaggiotti G, Tack J, Garrido Jr AB, et al. Adjustable totally implantable intragastric prosthesis (ATIIP)-Endogast for treatment of morbid obesity: one-year follow-up of a multicenter prospective clinical survey. Obes Surg. 2007;17(7):949–56.
Mion F, Ibrahim M, Marjoux S, Ponchon T, Dugardeyn S, Roman S, Deviere J. Swallowable Obalon® gastric balloons as an aid for weight loss: a pilot feasibility study. Obes Surg. 2013;23(5):730–3.
Genco A, Balducci S, Bacci V, et al. Intragastric balloon or diet alone? A retrospective evaluation. Obes Surg. 2008;18(8):989–92.
Genco A, Maselli R, Cipriano M, et al. Long-term multiple intragastric balloon treatment: a new strategy to treat morbid obese patients refusing surgery. Prospective 6-year follow-up study. Surg Obes Relat Dis. 2014;10(2):307–11.
Busetto L, Segato G, De Luca M, et al. Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case–control study. Obes Surg. 2004;14(5):671–6.
Genco A, Bruni T, Doldi SB, et al. Bioenterics intragastric balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15:1161–4.
Weiner R, Gutberlet H, Bockhorn H. Preparation of extremely obese patients for laparoscopic gastric banding by gastric balloon therapy. Obes Surg. 1999;9:261–4.
Genco A, Lorenzo M, Baglio G, et al. Does the intragrastric balloon have a predictive role in subsequent LAP-BAND surgery? Italian multicenter study results at 5-years follow-up. Surg Obes Relat Dis 2014;10(3):474–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Genco, A., Maselli, R., Cipriano, M., Soricelli, E., Casella, G., Redler, A. (2015). Endoscopic Treatment: Intragastric Balloon. In: Lucchese, M., Scopinaro, N. (eds) Minimally Invasive Bariatric and Metabolic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-15356-8_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-15356-8_14
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15355-1
Online ISBN: 978-3-319-15356-8
eBook Packages: MedicineMedicine (R0)